Skip to main content

AvePoint, Inc.

For the period ended Dec 31, 2025. Filed Feb 26, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 26, 2026

AVPT$16.89+0.5%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 8. Consolidated Statements of Cash Flows

Consolidated Statements of Cash Flows

(In thousands)

For the Year Ended
December 31,
202520242023
Operating activities
Net income (loss)$35,120$(29,142)$(21,501)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization6,2055,3824,687
Operating lease right-of-use assets expense8,6146,2706,234
Foreign currency remeasurement loss4,497866—
Stock-based compensation39,31539,05936,048
Deferred income taxes(2,240)498(864)
Allowance for credit loss on notes receivable4,037——
Other468(67)1,068
Change in value of earn-out and warrant liabilities(408)37,27611,454
Changes in operating assets and liabilities:
Accounts receivable(31,300)(4,898)(19,448)
Prepaid expenses and other current assets(2,658)(3,350)(2,773)
Deferred contract costs and other assets(11,266)(8,482)(7,687)
Accounts payable, accrued expenses and other current liabilities, and other liabilities3,38322,4436,882
Operating lease liabilities(8,636)(6,397)(6,273)
Deferred revenue40,12629,43626,867
Net cash provided by operating activities85,25788,89434,694
Investing activities
Maturities of investments1675,3532,620
Purchases of investments(167)(1,819)(3,497)
Cash paid in business combinations, net of cash acquired(14,893)——
Capitalization of internal-use software(1,624)(1,211)(1,434)
Purchase of property and equipment(3,683)(3,044)(2,087)
Issuance of notes receivables—(1,750)(1,250)
Other investing activities—(130)—
Net cash used in investing activities(20,200)(2,601)(5,648)
Financing activities
Purchase of common stock(49,750)(33,053)(39,036)
Proceeds from warrant exercises168,18917,182—
Proceeds from stock option exercises17,70911,0335,569
Repurchase of noncontrolling interest(12,148)——
Funds held on behalf of others6,065——
Funds released on behalf of others(6,065)——
Redemption of redeemable noncontrolling interest—(6,130)—
Purchase of public warrants—(3,991)—
Company earn-out shares settled in cash—(572)—
Other financing activities(9)(6)(200)
Net cash provided by (used in) financing activities123,991(15,537)(33,667)
Effect of exchange rates on cash1,277(3,183)595
Net increase (decrease) in cash and cash equivalents190,32567,573(4,026)
Cash and cash equivalents at beginning of period290,735223,162227,188
Cash and cash equivalents at end of period$481,060$290,735$223,162
Supplemental disclosures of cash flow information
Income taxes paid$6,831$6,882$6,112
Company earn-out shares issuance$—$53,871$—
Unpaid purchase consideration transferred in connection with the business combination$5,499$—$—
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.